Acquisition of Medicines and Chlorhexidine. Division of Pharmacy.

• Country: Argentina
• Summary: Acquisition of Medicines and Chlorhexidine. Division of Pharmacy.
• ART Ref No: 108407115
• Deadline: 16 Oct 2024
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: ARS 4329923.75
• Notice Type: Tender
• Document Ref. No.: 417-1943-CDI24
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• Sulfate barium Model: 94 %, dust, in bottle x 270 g, calcium solution model Chloride: 10 %, in ampoule x 10 ml variety: chloride, sterile syringe. Model: polypropylene, capacity: 3 ml. Containing 80 U.I. of liophilized lithium heparin, balanced calcium and closing cap., phenobarbital. Model: 100 mg, injectable, in ampoule x 2 ml, etomidato. Model: 2 mg/ml, injectable solution, in ampoule x 10 ml., Paracetamol. Model: 500 mg, 10 mg x ml, intravenous injectable, in a blister bottle of X 50 ml., Melatonin. Model: 3 mg, in tablet, salmeterol + floticasone model: 25 µg of salmeterol + 250 µg of floticasone per dose, in aerosol x 120 dose, pressurized exclusively with hydrofluroalcan propellants (HFA), Levetiracem. Model: 100 mg/ml, oral solution, sodium montelukast. Model: 5 mg, in chewable tablet, sodium montelukast. Model: 4 mg, in chewable tablet, hydrochloride oxybutinine. Model: at 0.1 %, syrup, in bottle x 200 ml, sugammadex. Model: 100 mg/ml, intravenous injectable solution, in 10 roads of 2 ml, digluconate chlorhexidine. Model: at 20 %, solution, in bottle x 250 ml
• Documents:

 Tender Notice